Zobrazeno 1 - 10
of 1 252
pro vyhledávání: '"B, Wahren"'
Autor:
A. A. Latanova, S. Petkov, A. Kilpelainen, J. Jansons, O. E. Latyshev, Y. V. Kuzmenko, J. Hinkula, M. A. Abakumov, V. T. Valuev-Elliston, M. Gomelsky, V. L. Karpov, F. Chiodi, B. Wahren, D. Y. Logunov, E. S. Starodubova, M. G. Isaguliants
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-22 (2018)
Abstract DNA vaccines require a considerable enhancement of immunogenicity. Here, we optimized a prototype DNA vaccine against drug-resistant HIV-1 based on a weak Th2-immunogen, HIV-1 reverse transcriptase (RT). We designed expression-optimized gene
Externí odkaz:
https://doaj.org/article/1b38b6e3c64d4d089d2e1bc152026848
Autor:
S. Stenler, K. E. Lundin, L. Hansen, S. Petkov, N. Mozafari, M. Isaguliants, P. Blomberg, C. I. E. Smith, D. M. Goldenberg, C.-H. Chang, K. Ljungberg, J. Hinkula, B. Wahren
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 12, Pp 2849-2858 (2017)
Background: Genetic immunization is expected to induce the expression of antigens in a native form. The encoded peptide epitopes are presented on endogenous MHC molecules, mimicking antigen presentation during a viral infection. We have explored the
Externí odkaz:
https://doaj.org/article/ba7e0ede7ccb4c2db071810eddf1238f
Autor:
P. Palma, C. Foster, P. Rojo, P. Zangari, A. Yates, N. Cotugno, N. Klein, K. Luzuriaga, S. Pahwa, E. Nastouli, D.M. Gibb, W. Borkowsky, S. Bernardi, V. Calvez, E. Manno, Nadia Mora, A. Compagnucci, B. Wahren, M.Á Muñoz-Fernández, A. De Rossi, J. Ananworanich, D. Pillay, C. Giaquinto, P. Rossi
Publikováno v:
Journal of Virus Eradication, Vol 1, Iss 3, Pp 134-139 (2015)
ABSTRACT: Short summary: The EPIICAL (Early-treated Perinatally HIV-infected Individuals: Improving Children's Actual Life with Novel Immunotherapeutic Strategies) project arises from the firm belief that perinatally infected children treated with su
Externí odkaz:
https://doaj.org/article/368c227436ce422f9267890069592060
Autor:
J Hinkula, S Petkov, K Ljungberg, D Hallengärd, A Bråve, M Isaguliants, T Falkeborn, S Sharma, V Liakina, M Robb, M Eller, B Moss, G Biberfeld, E Sandström, C Nilsson, K Markland, P Blomberg, B Wahren
Publikováno v:
Heliyon, Vol 3, Iss 6, Pp e00339- (2017)
Background: In order to develop a more effective prophylactic HIV-1 vaccine it is important optimize the components, improve Envelope glycoprotein immunogenicity as well as to explore prime-boost immunization schedules. It is also valuable to include
Externí odkaz:
https://doaj.org/article/a3bba95eaff7427f813d733d783a2889
Autor:
S. Kutscher, L. W. Thørner, K. Kobayashi, S. Tcheung, S. D. Mahajan, L. Díaz Muñoz, M. Baseler, V. Erfle, M. T. M. Giret, P. M. Mwimanzi, C. Vandergeeten, C. Lane, I. I. Generalov, T. Amet, L. H. Harritshøj, M. Leal Noval, R. Aalinkeel, C. Erikstrup, R. Tanaka, S. J. Kent, I. Mangeot-Méderlé, K. Nayak, L. Gudmundsdotter, Z. Bernstein, M. Takiguchi, J. Hinkula, S. Hu, S. E. Johansson, A. Iwamoto, Shafiqur Rahman, N. Singh, J. L. Reynolds, Z. Nan, M. Moutschen, A. Corneau, S. Watanabe, T. Friesen, A. Kawana-Tachikawa, D. Byrd, H. Fausther-Bovendo, S. Sammicheli, P. Tantivorasit, K. Kärre, M. Takeda, M. Ishige, R. Davey, Elbert Reyes, S. Sharma, M. Ghabril, K. Ruxrungtham, M. Kannagi, T. Fujii, S. Allgayer, S. Subramanayam, T. A. Parhomenko, M. Raska, Sajib Chakraborty, H. Ullum, P. Debré, Q. Yu, S. Brighenti, J. Andersson, C. Thielen, J. Chandrabose, A. García Torre, J. Martinez, B. Saha, J. D. Rosales, M. Vajpayee, N. Ahmed, L. Berg, B. Wahren, M. Svensson, K. Imai, S. Rahmouni, J. D. Lifson, T. Miura, Y. Takahashi, N. Mehra, N. Tachikawa, C. Gilbert, R. C. Succi, S. Grutzmeier, H. Furukawa, P. Chatkulkawin, R. Brown, A. Busca, V. Vieillard, T. Chikata, Z. I. Akhmedjanova, H. Nakamura, M. C. Elliott, J. Adams, N. Obel, S. Hall, A. W. Chung, K. Honda, T. Masuda, K. Ochiai, E. M. Shankar, G. Roby, A. Shajiei, J. Adelsberger, S. A. Schwartz, M. Hashimoto, D. Hoffmann, T. Okamoto, C. Wilhelm, M. Singh, E. S. Odintsova, S. Nowroozalizadeh, K. Nakayama, C. J. Dembek, S. Sirivichayakul, Y. Mitsuki, M. J. Tremblay, S. Swaminathan, M. Larsson, S. Bayanolhagh, P. Singh, M. Tamura, K. Shibusawa, Y. Tamura, Melisa Colmenares, T. Ueno, V. N. Buneva, H. Gatanaga, Darrell L. Peterson, A. Hasegawa, S. Buranapraditkun, E. Rollman, Ashish Kumar, Y. Suzuki, N. Vivar, Aneesa Ansari, P. Ammaranond, H. Gaines, K. Sakai, Henry Montes, R. Le Grand, Y. Tanaka, A. Agosto-Mojica, G. A. Nevinsky, D. F. Nixon, M. Saxena, H. Park, B. Réthi, L. Czernekova, I. Stratov, Z. Moldoveanu, M. Jansson, F. Chiodi, Siham Salmen, J. Mestecky, M. Proschan, E. G. Kallas, M. Catalfamo, N. Dereuddre-Bosquet, M. Muñoz Fernández, G. Kaur, D. E. Sykes, T. Chida, K. Terahara, Y. Kiyoshi, N. Chalasani, C. J. Gouveia, A. Cosma, N. Ruffin, Lisbeth Berrueta, C. Rehm, C. Hsiao, Y. Yanagi, B. M. Ali, K. F. Che, S. Oka, Y. Tsunetsugu-Yokota, F. Maldarelli, N. Okamura, T. Koibuchi, R. Correa Rocha, A. A. Lambert, J. Novak, L. P. Sizyakina, S. Okada, Mustafizur Rahman, L. E. Hanna, L. Andersson, B. B. Nair, K. Zachova, F. D. Goebel, E. Sandström, J. R. Bogner, B. Hejdeman, T. Hayashi, G. Sharma
Publikováno v:
International Immunology. 22:iv63-iv69
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Clinical Diagnostic Laboratory Immunology. 1:336-341
The recognition sites for human antibodies which are cross-reactive between different types of enteroviruses were determined and characterized. Serum samples obtained from 58 patients with culture-confirmed enteroviral infections were analyzed in enz
Autor:
K, Hallermalm, S, Johansson, A, Bråve, M, Ek, G, Engström, A, Boberg, L, Gudmundsdotter, P, Blomberg, H, Mellstedt, R, Stout, M A, Liu, B, Wahren
Publikováno v:
Scandinavian journal of immunology. 66(1)
In preparation for a clinical trial in patients diagnosed with colorectal cancer, a vaccination strategy targeting the carcinoembryonic antigen (CEA) was evaluated in mice using a GMP-produced plasmid DNA vaccine, CEA66, encoding a truncated form of
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.